[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
IDEAYA Biosciences, Inc. Common Stock (IDYA)
IDEAYA Biosciences completes enrollment for its pivotal Phase 2/3 trial of darovasertib and crizotinib. This milestone is boosting investor confidence and driving positive social sentiment.
About IDEAYA Biosciences, Inc. Common Stock
IDEAYA Biosciences, Inc. is a biotechnology company focused on developing cancer therapies.
IDEAYA Biosciences, Inc. Common Stock uses the ticker $IDYA for trading. Listed in the Stocks category within the Healthcare sectors.
Insights
- IDEAYA Biosciences, Inc. Common Stock (IDYA) social dominance is up XXXXX% from the previous week.
- IDEAYA Biosciences, Inc. Common Stock (IDYA) Galaxy Score™ is up XX% from the previous week.
- IDEAYA Biosciences, Inc. Common Stock (IDYA) engagements is up XXXXX% from the previous week.
- IDEAYA Biosciences, Inc. Common Stock (IDYA) posts created is up XX% from the previous week.
Price: $XX
Price 24-Hour Time-Series Raw Data
The stock price is nearing its 52-week high, supported by positive analyst ratings and favorable social sentiment, including a 'Buy' rating and a price target of $XX from Truist Securities. The recent IND clearance for IDE034 further bolsters investor confidence and indicates strong upward momentum.
24-Hour: XXXX% 7-Day: -XXXX% 30-Day: XXXX%
1-Year High: $XX on 2025-12-04
1-Year Low: $XXXXX on 2025-04-08
AltRank: XXX
AltRank 24-Hour Time-Series Raw Data
IDEAYA Biosciences, Inc. Common Stock (IDYA) is currently AltRank #849 based on combined combined social and market metrics
Daily Average: XXX
X Week: XXX +506
X Month: XXX -XXXXX
X Months: XXX -XXXXX
X Year: XXX -XX
1-Year High: XXXXX on 2025-08-29
1-Year Low: XX on 2025-01-11
Galaxy Score: XXXXX
Galaxy Score 24-Hour Time-Series Raw Data
Current Value: XXXXX
Daily Average: XX
X Week: XX +14
X Month: XX +2
X Months: XX +2
X Year: XX +29
1-Year High: XX on 2025-07-24
1-Year Low: X on 2025-06-11
Engagements: XXXXX (24h)
Engagements 24-Hour Time-Series Raw Data
Current Value: XXXXX
Daily Average: XXXXX
X Week: XXXXXX +67%
X Month: XXXXXXX -XXXX%
X Months: XXXXXXXXX +62%
X Year: XXXXXXXXX +66%
1-Year High: XXXXXX on 2025-09-08
1-Year Low: XXX on 2025-05-10
Engagements by network (24h): X: XXXXX
Mentions: XX (24h)
Mentions 24-Hour Time-Series Raw Data
Current Value: XX
Daily Average: XX
X Week: XXX -XX%
X Month: XXX +7.90%
X Months: XXXXX +89%
X Year: XXXXX +117%
1-Year High: XXX on 2025-06-28
1-Year Low: XX on 2025-12-14
Mentions by network (24h): X: XXX
Creators: XX (24h)
Creators 24-Hour Time-Series Raw Data
XX unique social accounts have posts mentioning IDEAYA Biosciences, Inc. Common Stock (IDYA) in the last XX hours which is down XX% from XX in the previous XX hours
Daily Average: XX
X Week: XXX +3.50%
X Month: XXX +21%
X Months: XXXXX +204%
X Year: XXXXX +120%
1-Year High: XXX on 2025-06-28
1-Year Low: X on 2025-06-01
The most influential creators that mention IDEAYA Biosciences, Inc. Common Stock in the last XX hours
| Creator | Rank | Followers | Posts | Engagements |
|---|---|---|---|---|
| @BiopharmIQ | X | XXXXXX | X | XXXXX |
| @SteveDJacobs | X | XXXXX | X | XX |
| @seedytx19 | X | XXXXX | X | X |
Sentiment: XXX%
Sentiment 24-Hour Time-Series Raw Data
Current Value: XXX%
Daily Average: XX%
X Week: XXX% no change
X Month: XXX% +33%
X Months: XXX% +12%
X Year: XXX% +30%
1-Year High: XXX% on 2025-03-17
1-Year Low: XX% on 2025-02-04
Most Supportive Themes:
- Pipeline Potential: (45%) The company's drug pipeline, including its Uveal Melanoma drug and DLL3 programs, is expected to have a significant market impact.
- Analyst Ratings: (25%) Positive analyst ratings from Barclays and Citizens, with price targets of $XX and $XX respectively, indicate confidence in the stock's future performance.
Most Critical Themes:
- Biotech Volatility: (10%) The inherent volatility of the biotech sector requires careful monitoring of overall market trends.
Social Dominance: XXXXXXX%
Social Dominance 24-Hour Time-Series Raw Data
Current Value: XXXXXXX%
Daily Average: XXXXX%
X Week: XXXXX% +0.0019%
X Month: XXXXXX% -XXXXXX%
X Months: XXXXXX% -XXXXXX%
X Year: XXXXXX% -XXXXX%
1-Year High: XXXXX% on 2024-12-31
1-Year Low: XXXXXX% on 2025-06-01
Market Dominance: XXXXXXX%
Market Dominance 24-Hour Time-Series Raw Data
Current Value: XXXXXXX%
Daily Average: X%
1-Year High: XXXXX% on 2025-11-26
1-Year Low: XXXXXXX% on 2025-03-19
Market Cap: $XXXXXXXXXXXXX
Market Cap 24-Hour Time-Series Raw Data
Current Value: $XXXXXXXXXXXXX
Daily Average: $XXXXXXXXXXXXX
X Week: $XXXXXXXXXXXXX +$0.03%
X Month: $XXXXXXXXXXXXX +$5.90%
X Months: $XXXXXXXXXXXXX +$55%
X Year: $XXXXXXXXXXXXX +$37%
1-Year High: $XXXXXXXXXXXXX on 2025-12-04
1-Year Low: $XXXXXXXXXXXXX on 2025-04-08
Top IDEAYA Biosciences, Inc. Common Stock Social Posts
Top posts by engagements in the last XX hours
Showing only X posts for non-authenticated requests. Use your API key in requests for full results.
"$IDYA squeeze setup turning explosive $SNPS $QTTB #jonita #Rashmer"
X Link @RivardJamey 2025-12-13T02:01Z XX followers, XXX engagements
"♈🤪🧑♍ Honestly the best financial Twitter/Telegram/Channel follow I have is Prof. @TwV6CPgEkuVvMHe. Free professional and incredibly useful signals. #Stock #Netcapital $NCPL #NYSE💡 $INTU #CryptoNews💟 $IDCC #MarketMaker❌ $IDYA #Restructuring👏 $IDN"
X Link @broughton_15578 2025-12-13T01:40Z XX followers, XX engagements
"🥌🧃🥈🌀 I recommend a stock analyst @TwV6CPgEkuVvMHe. The signals he shares on X have been rising daily and are worth following. #Stock #RYTHM $MKZR #Finance 🏴 $JBI #Fund🐥 $TSM #Diversification🦞 $IDYA #Nvidia♓ $INCY"
X Link @SkinnerLee31145 2025-12-13T00:33Z XX followers, XX engagements
"⛅🔻 For those asking how I find my trading ideas: I follow Prof. @Basma2937's free daily alerts. His analysis as a finance professor is next level. #Stock #WeShop $RYM #MP🧪 $IPAR #Bitcoin🐏 $ASML #Equities🥋 $IRWD #Compliance🎶 $IDYA"
X Link @AntonioSki97171 2025-12-12T18:46Z XX followers, XX engagements